Comparison of the effect Emla Cream? local lavender essential oil and Cold Compress on the pain intensity of the injection site and Comfort of heart Patients Receiving Enoxapari

Phase 2

Recruiting

• Conditions: Injection pain.; Other acute postprocedural pain; G89.18

• Registration Number: IRCT20100829004655N9
• Lead Sponsor: Kashan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 30 April 2018

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

1.age between 18-85 years old
full consciousness
ability to communicate
not a severe pain in other areas
no history of prescribed Enoxaparin
no scarring and lesions at the injection site
no history of allergy to lidocaine & Prilocain
no history of allergy to Lavender

Exclusion Criteria

loss of consciousness
prescription of narcotic and non-narcotic analgesics 2 hours before injection
injection of other drug in the abdomen during the study

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Injection pain. Timepoint: Immediate,5 &10 minute after injection. Method of measurement: Using the VAS scale & record severe pain intensity.;The amount Patient comfort. Timepoint: Immediate,5 &10 minute after injection. Method of measurement: visual scale of comfor& record severe comfort intensity Using the.